Eliot Brinton, MD, FAHA, FNLA, president and director of the Utah Lipid Center, discusses the benefits of fasting lipid profiles in predicting cardiovascular risk.
Highlights from the 2017 American College of Cardiology Scientific Session & Expo.
Both iFR and FFR groups experienced similar rates of composite nonfatal myocardial infarction, unplanned revascularization, or all-cause death within 1 year post-procedure.
Although more women are admitted with Takotsubo cardiomyopathy, more men ultimately die.
Incidence of major bleeding events was lower with dabigatran vs warfarin in atrial fibrillation ablation.
Researchers found that same-day discharge in PCI for non-ST-segment elevation acute coronary syndromes.
A longer wait between administration of antiplatelet therapy and primary percutaneous intervention has been linked to improved coronary reperfusion.
Patients with higher baseline blood pressure had higher 6-month combined cardiovascular disease incidence after adjustments.
Researchers conducted a meta-analysis to compare the safety and efficacy of sotalol vs amiodarone or beta-blockers to prevent supraventricular arrhythmias.
Researchers studied the safety and efficacy of cangrelor in patients receiving unfractionated heparin for PCI.
